• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

FAQ’s: Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy

April 2, 2016 By Dr. Jeremy Feldman

PAH patient story

Your Questions Answered. Our readers have submitted some great questions.  We value your questions and encourage you to continue to tell us about your interests and questions. What is happening with the implanted Remodulin Pump? The FDA recently announced they are not ready to approve the implanted pump system for the delivery of continuously infused Remodulin.  They are … [Read more...]

Update on Medical Management of Pulmonary Hypertension in Congenital Heart Disease (PAH-CHD)

February 29, 2016 By Dr. Jeremy Feldman

Update on PAH Treatments

In 1995 epoprostenol, a continuously infused prostanoid medication, was approved for the treatment of PAH. Although this medicine worked to decrease pulmonary artery pressures, there were many risks with this therapy in congenital heart disease (CHD) patients.  Since an intravenous catheter was required, there was a small but real risk of blood stream infection.  There was also … [Read more...]

Eisenmenger’s Syndrome

February 9, 2016 By Dr. Jeremy Feldman

Pulmonary hypertension and pregnancy

Congenital Heart Disease & Eisenmenger's Syndrome February 4th-7th is Congenital Heart Disease Awareness week.  The incidence of congenital heart disease today is 1:100 live births.  With today’s post , I wanted to discuss a complicated problem that adults who are born with congenital heart disease may suffer from for their entire lives: Eisenmenger’s Syndrome. A … [Read more...]

Patients Helping Other Patients

February 2, 2016 By Dr. Jeremy Feldman

PH Support Group

We are lucky to have some patient contributors to our website.  I have known Donna and Patricia for many years.  They have been very active in the local pulmonary hypertension community.  They offer the following insight into the role of support groups. By Patricia Harrington and Donna Green The support of family and friends is a key element of coping with any complex medical … [Read more...]

Congenital Heart Disease: An Overview

January 22, 2016 By Dr. Jeremy Feldman

Dr. Tabitha Moe

What is Congenital Heart Disease? As we are developing from a single egg fertilized by a single sperm, cells divide and begin to develop into the different tissues of our adult bodies.  This is a very complex process that is like a kind of perfectly choreographed ballet.  A special cluster of cells slowly differentiates into the cardiovascular system.  Cells that become the … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PAH couple

FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & Pulmonary Hypertension

By Dr. Jeremy Feldman

Is Psoriasis associated with pulmonary arterial hypertension? Psoriasis is an autoimmune skin disorder characterized by

generic medication

Generic Adcirca is Coming!

By Dr. Jeremy Feldman

After many years under patent protection, the generic medication Tadalafil will soon be available. What does this mean

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives